Login to Your Account

Other News To Note

Monday, June 18, 2012
• Questcor Pharmaceuticals Inc., of Anaheim, Calif., said its initial commercialization plans for rheumatology drug H.P. Acthar Gel (repository corticotropin injection) include the creation of a 12-member sales force, plus a national sales director and two regional sales managers.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription